These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7544198)

  • 1. The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
    Watson JW; Gonsalves SF; Fossa AA; McLean S; Seeger T; Obach S; Andrews PL
    Br J Pharmacol; 1995 May; 115(1):84-94. PubMed ID: 7544198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the NK1 receptor antagonist CP-99,994 on emesis and c-fos protein induction by loperamide in the ferret.
    Zaman S; Woods AJ; Watson JW; Reynolds DJ; Andrews PL
    Neuropharmacology; 2000 Jan; 39(2):316-23. PubMed ID: 10670427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets.
    Gonsalves S; Watson J; Ashton C
    Eur J Pharmacol; 1996 Jun; 305(1-3):181-5. PubMed ID: 8813551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.
    Tattersall FD; Rycroft W; Francis B; Pearce D; Merchant K; MacLeod AM; Ladduwahetty T; Keown L; Swain C; Baker R; Cascieri M; Ber E; Metzger J; MacIntyre DE; Hill RG; Hargreaves RJ
    Neuropharmacology; 1996; 35(8):1121-9. PubMed ID: 9121615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
    Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ
    Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-emetic action of the neurokinin(1) receptor antagonist CP-99,994 does not require the presence of the area postrema in the dog.
    Andrews PL; Kovacs M; Watson JW
    Neurosci Lett; 2001 Nov; 314(1-2):102-4. PubMed ID: 11698156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-emetic effects of a novel NK-1 receptor antagonist HSP-117 in ferrets.
    Saito R; Suehiro Y; Ariumi H; Migita K; Hori N; Hashiguchi T; Sakai M; Saeki M; Takano Y; Kamiya H
    Neurosci Lett; 1998 Oct; 254(3):169-72. PubMed ID: 10214984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of CP-99994 on the responses to provocative motion in the cat.
    Lucot JB; Obach RS; McLean S; Watson JW
    Br J Pharmacol; 1997 Jan; 120(1):116-20. PubMed ID: 9117085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
    Gardner CJ; Twissell DJ; Dale TJ; Gale JD; Jordan CC; Kilpatrick GJ; Bountra C; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3158-63. PubMed ID: 8719790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of tachykinin NK-1 receptors in emetic action in the area postrema of ferrets].
    Saito R; Ariumi H; Kubota H; Nago S; Honda K; Takano Y; Kamiya H
    Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():209P-214P. PubMed ID: 10629882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994.
    Tattersall FD; Rycroft W; Hill RG; Hargreaves RJ
    Neuropharmacology; 1994 Feb; 33(2):259-60. PubMed ID: 8035913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets.
    Tattersall FD; Rycroft W; Cumberbatch M; Mason G; Tye S; Williamson DJ; Hale JJ; Mills SG; Finke PE; MacCoss M; Sadowski S; Ber E; Cascieri M; Hill RG; MacIntyre DE; Hargreaves RJ
    Neuropharmacology; 2000 Feb; 39(4):652-63. PubMed ID: 10728886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.
    Rudd JA; Jordan CC; Naylor RJ
    Br J Pharmacol; 1996 Nov; 119(5):931-6. PubMed ID: 8922742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
    Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
    Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tachykinin NK1 receptor antagonist GR205171 abolishes the retching activity of neurons comprising the central pattern generator for vomiting in dogs.
    Fukuda H; Koga T; Furukawa N; Nakamura E; Shiroshita Y
    Neurosci Res; 1999 Jan; 33(1):25-32. PubMed ID: 10096468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenidol has no actual broad antiemetic activity in dogs and ferrets.
    Nakayama H; Yamakuni H; Nakayama A; Maeda Y; Imazumi K; Matsuo M; Mutoh S
    J Pharmacol Sci; 2004 Nov; 96(3):301-6. PubMed ID: 15528840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret.
    Tattersall FD; Rycroft W; Hargreaves RJ; Hill RG
    Eur J Pharmacol; 1993 Nov; 250(1):R5-6. PubMed ID: 8119305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret.
    Andrews PL; Bhandari P
    Neuropharmacology; 1993 Aug; 32(8):799-806. PubMed ID: 8413843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.
    Darmani NA; Wang Y; Abad J; Ray AP; Thrush GR; Ramirez J
    Brain Res; 2008 Jun; 1214():58-72. PubMed ID: 18471804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists.
    Rupniak NM; Tattersall FD; Williams AR; Rycroft W; Carlson EJ; Cascieri MA; Sadowski S; Ber E; Hale JJ; Mills SG; MacCoss M; Seward E; Huscroft I; Owen S; Swain CJ; Hill RG; Hargreaves RJ
    Eur J Pharmacol; 1997 May; 326(2-3):201-9. PubMed ID: 9196273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.